View in EDS HTML Full Text PDF Full Text

Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Saved in:
Bibliographic Details
Title: Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Authors: van Asselt ADI; Department of Health Sciences, University of Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. a.d.i.van.asselt@umcg.nl.; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. a.d.i.van.asselt@umcg.nl., Armstrong N; Kleijnen Systematic Reviews Ltd, York, UK., Kimman M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Peeters A; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands., McDermott K; Kleijnen Systematic Reviews Ltd, York, UK., Stirk L; Kleijnen Systematic Reviews Ltd, York, UK., Ahmadu C; Kleijnen Systematic Reviews Ltd, York, UK., Govers TM; Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands., Hoentjen F; Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada.; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands., Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Grimm SE; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Source: PharmacoEconomics [Pharmacoeconomics] 2023 Mar; Vol. 41 (3), pp. 239-251. Date of Electronic Publication: 2023 Feb 01.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36725788
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Asselt+ADI%22">van Asselt ADI</searchLink>; Department of Health Sciences, University of Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. a.d.i.van.asselt@umcg.nl.; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. a.d.i.van.asselt@umcg.nl.<br /><searchLink fieldCode="AU" term="%22Armstrong+N%22">Armstrong N</searchLink>; Kleijnen Systematic Reviews Ltd, York, UK.<br /><searchLink fieldCode="AU" term="%22Kimman+M%22">Kimman M</searchLink>; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Peeters+A%22">Peeters A</searchLink>; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22McDermott+K%22">McDermott K</searchLink>; Kleijnen Systematic Reviews Ltd, York, UK.<br /><searchLink fieldCode="AU" term="%22Stirk+L%22">Stirk L</searchLink>; Kleijnen Systematic Reviews Ltd, York, UK.<br /><searchLink fieldCode="AU" term="%22Ahmadu+C%22">Ahmadu C</searchLink>; Kleijnen Systematic Reviews Ltd, York, UK.<br /><searchLink fieldCode="AU" term="%22Govers+TM%22">Govers TM</searchLink>; Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoentjen+F%22">Hoentjen F</searchLink>; Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada.; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Joore+MA%22">Joore MA</searchLink>; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Grimm+SE%22">Grimm SE</searchLink>; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2023 Mar; Vol. 41 (3), pp. 239-251. <i>Date of Electronic Publication: </i>2023 Feb 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36725788
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-023-01244-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 239
    Titles:
      – TitleFull: Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Asselt ADI
      – PersonEntity:
          Name:
            NameFull: Armstrong N
      – PersonEntity:
          Name:
            NameFull: Kimman M
      – PersonEntity:
          Name:
            NameFull: Peeters A
      – PersonEntity:
          Name:
            NameFull: McDermott K
      – PersonEntity:
          Name:
            NameFull: Stirk L
      – PersonEntity:
          Name:
            NameFull: Ahmadu C
      – PersonEntity:
          Name:
            NameFull: Govers TM
      – PersonEntity:
          Name:
            NameFull: Hoentjen F
      – PersonEntity:
          Name:
            NameFull: Joore MA
      – PersonEntity:
          Name:
            NameFull: Grimm SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2027
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1